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ropBA B S T R A C T
Aims and objectives: Early detection of multidrug-resistant tuberculosis (MDR-TB) is essen-
tial to prevent its transmission in the community and to initiate an effective anti-TB treat-
ment regimen. The objective of this study is to evaluate molecular technique high
resolution melting curve (HRM) assay to rapidly detect resistance-conferring mutations
in rpoB and katG genes.
Methods: HRM analysis was used to screen 95 Mycobacterium tuberculosis (MTB) clinical
isolates including 20 rifampin resistant (RIF-R), 21 isoniazid resistant (INH-R), and 54 fully
susceptible (S) isolates determined by proportion method of drug susceptibility testing. 19
MTB isolates with known drug susceptibility genotypes were used as control strains for
initial validation of the assay. Polymerase chain reaction (PCR) amplicons from rpoB and
katG genes were sequenced to investigate the frequency and type of mutations and to
confirm HRM results.
Results: All RIF-S and INH-S isolates generated wild-type HRM curves and were accurately
identified as susceptible by this method. Similarly 19 out of 20 RIF-R and 18 out of 21 INH-R
isolates correctly exhibited mutant-type HRM curves. These results were similar to those
obtained by direct sequencing. However, 1 RIF-R and 3 INH-R isolates were falsely identified
as susceptible by HRM assay. These strains were confirmed as having no mutation in their
target regions by sequencing. The main mutations involved in RIF and INH resistance were
found at codons rpoB531 (60% of RIF-R isolates) and katG315 (85.7% of INH-R isolates),
respectively.
Conclusions: HRM was found to be a reliable, rapid and low-cost method to characterize
drug susceptibility of clinical TB isolates in resource-limited settings.
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